Challenges Facing the utility of pf specific malaria rapid Diagnostic tests(mrdts)-a case report at Webuye County Hospital-Bungoma County. Challenges Facing.

Slides:



Advertisements
Similar presentations
MICS3 Data Analysis and Report Writing
Advertisements

Assessment of three new parasite lactate dehydrogenase (pan-pLDH) tests for diagnosis of uncomplicated malaria Assessment of three new parasite lactate.
Spectacular decline of malaria on Malaita: A review of laboratory-based data Helen Polosovai BApplSc(MedLab) AAH Laboratory Dept.
Census, Mapping and Demographic Survey in an Urban Area of Uganda Jennifer Davis University of California, San Francisco, MS4.
Doctors For Life International: An NGO’s perspective on Malaria in Southern Africa Bola Omoniyi, Ph.D. http:
National Malaria Centre of Cambodia Rational Pharmaceutical Management Plus Program World Health Organization European Commission Cambodian Malaria Control.
Malaria Challenge Introduction to malaria. Malaria is a life threatening disease which is transmitted to humans through the bites of infected female Anopheles.
Drug Policy Bangladesh Presented by Dr ATM Mustafa Kamal National Programme Manager Malaria and Vector Borne Disease Control DGHS, Dhaka, Bangladesh.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
MALARIA TREATMENT PROTOCOL Third edition June 2007 Ministry of Health Republic Democratic of Timor- Leste.
Malaria in Zambia A refresher Scope of Presentation  Background on Malaria  Overview of malaria in Zambia  Interventions  Impact  Active Case.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 97 Antiprotozoal Drugs I: Antimalarial Agents.
MALARIA History The disease How people get Malaria ( transmission) Symptoms and Diagnosis Treatment Preventive measures Where malaria occurs in the world.
Current Malaria Situation -Bangladesh MALARIA FACTS Country Area 147,570 sq. km and Pop million 13 out of 64 districts are high endemic 13.3 million.
FAMILY MEDICINE PRACTICE EXPERIENCES FROM TURKEY Dokuz Eylül University Medicine Faculty Family Medicine Department December 2014, Zagreb.
Malaria treatment. Dr abdulrahman al shaikh.. Introduction million patients died because of malaria every year. Most deaths due to Plasmodium Falciparum.
3 July  Background Information  Objectives  Methodology  Results  Discussion  Conclusion  Recommendation Presentation Outline.
World Health Organization
Management of severe falciparum malaria Dr SK Mishra,MD Ispat General Hospit al, Rourkela India.
Start on the T/F quiz at your desk…Let’s see what you already know.
Module 7: Malaria and HIV/AIDS Palliative Care for People Living with HIV/AIDS.
PRACTICAL ON BLOOD PARASITES
Overview of Cambodia Laboratory System & Organizational work flow Structure Dr. Lek Dysoley CNM 8-12 April, 2013.
Unit 5: IPT Isoniazid TB Preventive Therapy
T e c h n i c a l S e m i n a r s Malaria Overview Overview Case DefinitionCase Definition Kills Quickly Malaria Risk HighHigh Low How to Assess ClassificationLowHow.
Synthetically Engineered Artemisinin Lianne Ryan.
Malaria Case management KPA conference. Presentation outline  Introduction  National malaria strategy  Case management targets  AMFm subsidy  The.
LOW RELIABILITY OF HOME-BASED DIAGNOSIS OF MALARIA IN A RURAL COMMUNITY IN WESTERN KENYA Rose Kakai (1), Josephine Nasimiyu (2), 1 Wilson Odero (1) 1 Maseno.
1 Malaria Prevention and Control in Ethiopia Dr Daddi Jima National Malaria Control Program, Ethiopia.
Malaria--Background Occurs in > 90 countries million cases a year 2 million deaths a year –>90% deaths in sub-Saharan Africa –Most deaths in children.
Current National Drug Policies in Lao P.D.R. By Dr Samlane Phompida Centre of Malariology, Parasitology & Entomology.
Malaria By Alexandra Graziano 10 White What is this disease? Malaria is an infection of the blood caused by a parasite called Plasmodium, which.
Issues in malaria diagnosis and treatment May 31, 2007 Jacek Skarbinski, MD Malaria Branch Centers for Disease Control and Prevention.
Leadership & Global Health
Dr Zahra Rashid Khan, Assistant Professor, Hematology Department of Pathology.
Impact of Early Infant Diagnostic (EID) Testing for HIV Exposed Infants in Namibia Dr. Ndapewa Hamunime (MOHSS) Dr. Andreas Shiningavamwe (NIP) Republic.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia & Dr. Michael Lynch Epidemiologist.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia.
Integrated Management of Childhood Illnesses
Malaria pan-R Malaria cassette. Agenda Disease overview Infectious agents Diagnosis pan-R Malaria cassette: specifications Conclusion.
AMI -RAVREDA – USAID Project report, Colombia March 2009 Preliminary results on efficacy and Safety of Coartem ® on the treatment of Acute Uncomplicated.
+ Quality Assessment of Malaria Diagnosis on the Thai-Burma Border Jaime Moo-Young Noon Conference, Harborview Medical Center June 1, 2010.
IMPROVING ADHERENCE TO MALARIA TREATMENT FOR CHILDREN: THE USE OF PRE-PACKAGED CHLOROQUINE TABLETS VRS. SYRUP Evelyn K. Ansah¹, John O.Gyapong², Irene.
Improving Chloroquine Prescribing in PrivateClinics in Lagos State, Nigeria *Taylor O, **Momodu RO, **Odufalu O *World Health Organisation **National.
Strengthening SME system for national programmes from transmission reduction to elimination phase China Dr Li Xiao Hong National Program officer WHO, China.
Is antimalarial treatment in pregnant women as effective as that in non- pregnant women? Elizabeth Juma, Rashid Aman, Florence Oloo, Bernhards Ogutu Centre.
New Insights into the Diagnosis of Malaria Professor Bill Gilmore School of Healthcare Science, MMU.
Hot Topics in Infectious Diseases Giuseppe Nunnari.
Post-discharge chemoprevention of malaria in transfused children; a randomized trial in Uganda & Kenya R Idro, R Opoka, A Dhabangi, F TerKuile, and K Phiri.
Malaria Chemoprophylaxis and treatment By Mohammed Mahmoud, MD.
PREVALENCE OF MALARIA PARASITE IN DONATED BLOOD AT NAKASERO BLOOD BANK, UGANDA PRESENTED BY: MR. RONALD AYIKOBUA.
00002-E-1 – 1 December 2001 THE HIV/AIDS PANDEMIC Focus on Africa By Dr. David Elkins HIV/AIDS Prevention and Care Project Nairobi, Kenya September 2002.
1 Module 1: [Basic] Unit 1: [HIV Epidemics and Key Populations] Lesson 2: [Levels of HIV Epidemic in the World] “Community-Based HIV Surveillance” Online.
The malaria IQC serves as a milestone to improved accuracy in diagnosis of malaria parasites At Webuye District Hospital. INTRODUCTION The malaria microscopy.
Antimalarial Drugs.
Pitfalls in the Diagnosis and Management of malaria Dr Liz Hart.
Hindu College of PG Courses
Malaria in Tribal Areas
PRACTICAL ON BLOOD PARASITES
BY MAELO DAVID BUMULA SC BUNGOMA COUNTY
ARULANANDAM TERENCE.T 403(A)
Malaria Research in the Real World
By: Abdul Aziz Timbilla Ahmad Adel Kamil Al-Quraishi
MALARIA IN THE AMERICAS:
Kandeke C, Chibuta C, Banda D
TITLE Challenges Facing the utility of pf specific malaria rapid Diagnostic tests(mrdts)-a case report at Webuye County Hospital-Bungoma County. By Maelo.
Authors Mr. Ronald Ayikobua1, Dr. Patrick Vudriko 2, Mr. Ezra Musisi3  
EPIDEMIOLOGY OF MALARIA BY MBBSPPT.COM
WHO Community drug use practices in malaria in Cambodia: a cross-sectional study National Malaria Centre of Cambodia Rational Pharmaceutical Management.
Accuracy of RDT-based diagnosis of malaria in patients in rural and urban areas in the Ashanti Region of Ghana By Mutala Abdul-Hakim (MPhil Microbiology.
Presentation transcript:

Challenges Facing the utility of pf specific malaria rapid Diagnostic tests(mrdts)-a case report at Webuye County Hospital-Bungoma County. Challenges Facing the utility of pf specific malaria rapid Diagnostic tests(mrdts)-a case report at Webuye County Hospital-Bungoma County. By Maelo D.N Lab scientist, Rose Nasong’o MLT.

INTRODUCTION Malaria remains a public health problem in developing countries of Africa. In Kenya malaria caused by plasmodia species is endemic in western and coastal parts of Kenya and epidemic in Kenyan high altitude areas as highland malaria.Children under 5 yrs and pregnant women are at greater risk of malaria % of hospital admission in Kenya are due to Malaria with 3-5% in patient deaths.12% of outpatient clinic visits in Kenya are due to malaria.Each family spends Kshs.1,400 or more annually for treating malaria.170 million working days are lost each year.

INTRODUCTION Cont’d Webuye County hospital which is located in Webuye town off Bungoma-Kitale Highway serves As Referral hospital for 26 Health facilities in Bungoma East, other sub-counties in Bungoma county and the better part of kakamega County with an estimated population close to 1.8 million People. The broad objective of the study was to establish challenges faced by usage of pf specific mrdts in malaria diagnosis in Webuye County Hospital.The specific objective is to establish the presence of other plasmodium species other than pf among patients declared malaria negative by pf specific mrdts, ii To determine the percentage positivity per plasmodium species by microscopic examination using Giemsa stain and iii, To determine the Drug of choice for each plasmodium species.

METHODOLOGY Examination of Giemsa stained BS from mrdt negative patients using a microscope. Study site-Webuye County hospital Laboratory Study period-Jan to April 2015 Study Design-Case control study Study participant-one Consent-Study participant and close family relatives Inclusion Criteria-Residents from remote areas Exclusion criteria-Residents from Urban Areas Lab diagnosis-Rapid Diagnostic tests, thick and thin blood smears for mps. Clinical Guide-Malaria out patient algorithm

Results 20 randomly selected patients were tested by both mrdts and Microscopy and results were compared one patient with critical results was sampled as a case study Patient name was Laban Nakuku, 60 years old, Lab no-20774, From Silungai Location, Manda Sub- location, and Lurare Village with family of 5 children and five Grandchildren who stays in Home bordering Water Points. MRdts-Negative Bs for mps- (10-20 parasites/hpf), species-p.malariae Treatment-Al resistant, responded 2 nd line quinine, artesunate, Chloroquine

RAW DATA Lad id noTest1ResultsTest2ResultRemarks 19994mrdtsNegativeMicroscopy1-5 para/100wbcpf 20004`mrdtsnegativeMicroscopy1-4 p/100wbcpm 20014mrdtspositiveMicroscopy10-20p/100wbcPf,pm 20024mrdtsnegativeMicroscopy1-6p/100wbcpo 20044mrdtsnegativeMicroscopy2-7p/100wbcpm 20565mrdtspositiveMicroscopy20-30p/100wbcpf 20575mrdtsnegativeMicroscopy6-10p/wbcpm 20585mrdtsnegativeMicroscopy3-6p/100wbcpm 20603mrdtsnegativeMicroscopy2-4p/100wbcpo 20613mrdtsnegativeMicroscopy4-6p/100wbcpf 20724mrdtspositiveMicroscopy10-15p/100wbcpf 20734mrdtspositiveMicroscopy30-40p/100wbcpf 20744mrdtspostiveMicroscopy20-30p/100wbcpf 20754mrdtsnegativeMicroscopy10-20p/100wbcPf/po 20764mrdtsnegativeMicroscopy5-8 p/100wbc pf 20774mrdtsnegativeMicroscopy10-20p/100wbcP m 20784mrdtsnegativeMicroscopy1-3p/100wbcpm 21017mrdtsnegativeMicroscopy4-10p/100wbcPm/po 21027mrdtspositiveMicroscopy10-20p/100wbcpf

KEY: Pm-plasmodium malariae, po-plasmodium ovale, Pf-plasmodium falciparum, PV-plasmodium vivax

PERCENTAGE POSITIVITY PER SPECIES MONTH TOTAL TEST DONE TOTAL TEST POSITIVE PLASMODI UM FALCIPAR UM PLASMODI UM OVALE PLASMODI UM MALARIAE PLASMODI UM VIVAX JANUARY % % % % 0%0% FEBRUARY % % % % 0%0% MARCH % % % % 0%0% TOTAL % % % 0 0%

% POSITIVITY

Discussion The above results shows that out of 20 randomly selected samples 14 were negative for mrdts and were all positive for malaria microscopy since mrdts failed to pick malaria parasites from low density samples.The remaining 6 samples were positive in both methods suggesting that mrdts are best in high parasite samples specific for pf species while for different species only microscopy detected the cases.

MAP

MALARIA OUT PATIENT ALGORITHM

Recommended Drugs and Dosages Treatment of uncomplicated malaria First Line Treatment: ◦ Artemether + Lumefantrine (AL)  6 doses given over 3 days ◦ Below 5 Kg Half a tablet of AL under supervision, Dispersible AL is now available and is the most convenient to administer Second Line Treatment ◦ Dihydroartemisinin+Piperaquine (DHAP)  3 doses given over 3 days

Recommended Drugs and Dosages In treatment of severe malaria Administer artesunate 2.4 mg/kg body weight at 12 and 24 hours from commencement of the initial dose Then once a day until patient is able to take medication orally(maximum 5 days) Thereafter administer a 3 day course of AL OR oral quinine adults 2 tablets 3 times daily at interval of 8 hours for a period of 3 days

Recommended Drugs and Dosages OR iv Quinine administered as a loading dose Of 20 mg/kg quinine in dextrose to run for 4 hours Give 10 mg/kg(max 600mg) 8 hours from commencement of the initial dose of parenteral quinine Repeat 10 mg/kg quinine infusion every 8 hours until the patient can take medication orally

REFERENCES 1.WHO.Basic malaria microscopy:Part I and II Learners Guide.Geneva,World Health Organisation WHO,Malaria microscopy Quality assurance manual.Manila,Western pacific Regional office Practical laboratory manual for tropical countries by Monica Cheesbrough 2 nd edition

REFERENCES 4.Practical laboratory manual for centers in Eastern Africa by Jane Carter,Organes Lemma 5.Management of severe malaria. A practical handbook second edition. World Health Organisation,Geneva, Piola etal, Supervised Vs Unsupervised intake of six dose Artemether Lumefantrine for treatment of acute uncomplicated plasmodium falciparum in Mbarara Uganda:A randomimised trial.Lancet 2005: The British National Formulary 45 th March,2003

ACKNOWLEDGEMENT HUQAS scientific committee for review Webuye County Hospital Laboratory staff for their co operation DR Laktabai Moi University Malaria Research Co ordinator, For Availing mrdts For QA/QC SCLC bungoma East,Mr. B Sirrengo for Encouraging and mentorship